SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-024119
Filing Date
2018-10-11
Accepted
2018-10-10 19:23:23
Documents
4
Period of Report
2018-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20181010.htm 8-K 42420
2 EX-10.1 insy-ex101_6.htm EX-10.1 114199
3 EX-99.1 insy-ex991_7.htm EX-99.1 13187
4 GRAPHIC g20ageeffxyw000001.jpg GRAPHIC 5630
  Complete submission text file 0001564590-18-024119.txt   178951
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 181117042
SIC: 2834 Pharmaceutical Preparations